cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kamada Ltd
3 own
2 watching
Current Price
$5.18
$0.09
(1.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
230.72M
52-Week High
52-Week High
6.53000
52-Week Low
52-Week Low
4.08000
Average Volume
Average Volume
0.01M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
15.4016
iconMarket Capitalization230.72M
icon52-Week High6.53000
icon52-Week Low4.08000
iconAverage Volume0.01M
iconDividend Yield--
iconP/E Ratio15.4016
What does the Kamada Ltd do?
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to AATD, KAMRAB/KEDRAB a plasma-derived hyper- immunoglobulin for prophylactic treatment against rabies infection. It also provides KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, IXIARO vaccine, VIVOTIF for immunization against disease caused by salmonella typhi as well as PROCYSBI, LAMZEDE for metabolic disease, and ELIGARD to treat prostate cancer. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Read More
News & Events about Kamada Ltd.
Globe Newswire
1 year ago
REHOVOT, Israel and HOBOKEN, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today ...
Ticker Report
1 year ago
Kamada Ltd. (NASDAQ:KMDA Get Rating) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 500,700 shares, an increase of 5.1% from the October 31st total of 476,500 shares. Based on an average daily trading volume, of 33,200...
Globe Newswire
1 year ago
REHOVOT, Israel, July 15, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today that the Company, the Employees Union of Kamadas Beit Kama production facility in ...
Ticker Report
2years ago
StockNews.com assumed coverage on shares of Kamada (NASDAQ:KMDA Get Rating) in a research note released on Monday morning. The firm issued a buy rating on the biotechnology companys stock. Separately, Zacks Investment Research lowered Kamada from a buy rating to a hold rating in a ...
Frequently Asked Questions
Frequently Asked Questions
What is Kamada Ltd share price today?
plus_minus_icon
Can Indians buy Kamada Ltd shares?
plus_minus_icon
How can I buy Kamada Ltd shares from India?
plus_minus_icon
Can Fractional shares of Kamada Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Kamada Ltd stocks?
plus_minus_icon
What is today’s traded volume of Kamada Ltd?
plus_minus_icon
What is today’s market capitalisation of Kamada Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Kamada Ltd?
plus_minus_icon
What percentage is Kamada Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Kamada Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$5.18
$0.09
(1.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.87
$-0.14 (-1.75 %)
LUXFER HOLDINGS PLC
LUXFER HOLDINGS PLC
$9.68
$-0.11 (-1.12 %)
CORMEDIX INC
CORMEDIX INC
$5.33
$-0.12 (-2.20 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$4.30
$-0.24 (-5.29 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.87
$-0.14 (-1.75 %)
LUXFER HOLDINGS PLC
LUXFER HOLDINGS PLC
$9.68
$-0.11 (-1.12 %)
CORMEDIX INC
CORMEDIX INC
$5.33
$-0.12 (-2.20 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$4.30
$-0.24 (-5.29 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00